Peter Rasmussen
Comptroller/Controller/Auditor en ASCENDIS PHARMA A/S .
Fortuna: 53 540 $ al 30/04/2024
Cargos activos de Peter Rasmussen
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ASCENDIS PHARMA A/S | Comptroller/Controller/Auditor | 01/03/2014 | - |
Director Financiero/CFO | 01/02/2016 | 01/08/2016 |
Historial de carrera de Peter Rasmussen
Antiguos cargos conocidos de Peter Rasmussen.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AdvanDx, Inc.
AdvanDx, Inc. Medical SpecialtiesHealth Technology AdvanDx, Inc. provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. Its products include QuickFISH BC Tests, PNA FISH Tests, ASR PNA Probes, starter system, accessories and package inserts. The firm offers diagnostic solutions that include antimicrobial stewardship, blood culture contamination, staphylococcal bacteremia, enterococcal bacteremia, gram-negative bacteremia and candidemia. The company was founded by Henrik Stender and Thais T. Johansen in 2002 and is headquartered in Woburn, MA. | Director Financiero/CFO | 01/06/2008 | 01/08/2012 |
VELOXIS PHARMACEUTICALS A/S | Director Financiero/CFO | 01/01/2007 | 01/01/2008 |
Formación de Peter Rasmussen.
Copenhagen Business School | Graduate Degree |
Estadísticas
Internacional
Dinamarca | 4 |
Estados Unidos | 2 |
Operativa
Director of Finance/CFO | 3 |
Graduate Degree | 1 |
Comptroller/Controller/Auditor | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ASCENDIS PHARMA A/S | Health Technology |
Empresas privadas | 2 |
---|---|
AdvanDx, Inc.
AdvanDx, Inc. Medical SpecialtiesHealth Technology AdvanDx, Inc. provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. Its products include QuickFISH BC Tests, PNA FISH Tests, ASR PNA Probes, starter system, accessories and package inserts. The firm offers diagnostic solutions that include antimicrobial stewardship, blood culture contamination, staphylococcal bacteremia, enterococcal bacteremia, gram-negative bacteremia and candidemia. The company was founded by Henrik Stender and Thais T. Johansen in 2002 and is headquartered in Woburn, MA. | Health Technology |
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Peter Rasmussen
- Experiencia